Kenneth Hsu Eradicate Cancer 2018

Abstracts this author is presenting:

• Pre-clinical assessment of EphA2-directed CAR-T cell adoptive therapy for paediatric solid tumours — SESSION II: Chimeric Antigen Receptor – T cells (Part I)